Add Company
Join Now

Redpin Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Redpin Therapeutics's estimated annual revenue is currently $100.5k per year.(i)
  • Redpin Therapeutics's estimated revenue per employee is $100,500

Employee Data

  • Redpin Therapeutics has 1 Employees.(i)
  • Redpin Therapeutics grew their employee count by -50% last year.

Redpin Therapeutics's People

NameTitleEmail/Phone
1
FounderReveal Email/Phone
2
President and FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Redpin Therapeutics?

Redpin Therapeutics is a privately-held, preclinical stage gene therapy company based in New York City. We are developing a proprietary chemogenetics platform for targeted cell therapies that address currently intractable diseases of the nervous system. Our approach integrates powerful principles from synthetic biology, gene therapy, and traditional pharmacotherapy. Our science is based on the groundbreaking discovery and development of an ultrapotent ion channel-based chemogenetics platform that enables targeted cell activation or inhibition controlled by low doses of the anti-smoking drug varenicline (CHANTIX®).

keywords:N/A

N/A

Total Funding

1

Number of Employees

$100.5k

Revenue (est)

-50%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.1M10%N/A
#2
$0.1M10%N/A
#3
$0.1M1-75%N/A
#4
$0.1M1-80%N/A
#5
$15M10%N/A